Literature DB >> 22037500

Drug-induced GABA transporter currents enhance GABA release to induce opioid withdrawal behaviors.

Elena E Bagley1, Jennifer Hacker, Vladimir I Chefer, Christophe Mallet, Gavan P McNally, Billy C H Chieng, Julie Perroud, Toni S Shippenberg, MacDonald J Christie.   

Abstract

Neurotransmitter transporters can affect neuronal excitability indirectly via modulation of neurotransmitter concentrations or directly via transporter currents. A physiological or pathophysiological role for transporter currents has not been described. We found that GABA transporter 1 (GAT-1) cation currents directly increased GABAergic neuronal excitability and synaptic GABA release in the periaqueductal gray (PAG) during opioid withdrawal in rodents. In contrast, GAT-1 did not indirectly alter GABA receptor responses via modulation of extracellular GABA concentrations. Notably, we found that GAT-1-induced increases in GABAergic activity contributed to many PAG-mediated signs of opioid withdrawal. Together, these data support the hypothesis that GAT-1 activity directly produces opioid withdrawal signs through direct hyperexcitation of GABAergic PAG neurons and nerve terminals, which presumably enhances GABAergic inhibition of PAG output neurons. These data provide, to the best of our knowledge, the first evidence that dysregulation of a neurotransmitter transporter current is important for the maladaptive plasticity that underlies opiate withdrawal.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22037500     DOI: 10.1038/nn.2940

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  38 in total

Review 1.  Cellular and synaptic adaptations mediating opioid dependence.

Authors:  J T Williams; M J Christie; O Manzoni
Journal:  Physiol Rev       Date:  2001-01       Impact factor: 37.312

2.  Activation of a presynaptic glutamate transporter regulates synaptic transmission through electrical signaling.

Authors:  Margaret Lin Veruki; Svein Harald Mørkve; Espen Hartveit
Journal:  Nat Neurosci       Date:  2006-10-15       Impact factor: 24.884

3.  Increased opioid inhibition of GABA release in nucleus accumbens during morphine withdrawal.

Authors:  B Chieng; J T Williams
Journal:  J Neurosci       Date:  1998-09-01       Impact factor: 6.167

4.  Detoxification of rehabilitated methadone-maintained patients.

Authors:  P Cushman; V P Dole
Journal:  JAMA       Date:  1973-11-12       Impact factor: 56.272

5.  Anatomically distinct opiate receptor fields mediate reward and physical dependence.

Authors:  M A Bozarth; R A Wise
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

6.  Enhanced c-Fos in periaqueductal grey GABAergic neurons during opioid withdrawal.

Authors:  Billy C H Chieng; Catharina Hallberg; Fred J Nyberg; MacDonald J Christie
Journal:  Neuroreport       Date:  2005-08-22       Impact factor: 1.837

7.  Pre- and postsynaptic inhibition mediated by GABA(B) receptors in rat ventrolateral periaqueductal gray neurons.

Authors:  Kun Yang; Hidemasa Furue; Eiichi Kumamoto; Yuan-Xiang Dong; Megumu Yoshimura
Journal:  Biochem Biophys Res Commun       Date:  2003-03-07       Impact factor: 3.575

Review 8.  Tiagabine: a novel antiepileptic drug.

Authors:  M S Luer; D H Rhoney
Journal:  Ann Pharmacother       Date:  1998-11       Impact factor: 3.154

Review 9.  Neural substrates of opiate withdrawal.

Authors:  G F Koob; R Maldonado; L Stinus
Journal:  Trends Neurosci       Date:  1992-05       Impact factor: 13.837

10.  Biochemical correlates of morphine withdrawal. 2. Effects of clonidine.

Authors:  P S DiStefano; O M Brown
Journal:  J Pharmacol Exp Ther       Date:  1985-05       Impact factor: 4.030

View more
  23 in total

1.  Enhanced astroglial GABA uptake attenuates tonic GABAA inhibition of the presympathetic hypothalamic paraventricular nucleus neurons in heart failure.

Authors:  Sudip Pandit; Ji Yoon Jo; Sang Ung Lee; Young Jae Lee; So Yeong Lee; Pan Dong Ryu; Jung Un Lee; Hyun-Woo Kim; Byeong Hwa Jeon; Jin Bong Park
Journal:  J Neurophysiol       Date:  2015-06-10       Impact factor: 2.714

2.  GABA Uptake Inhibition Reduces In Vivo Extraction Fraction in the Ventral Tegmental Area of Long Evans Rats Measured by Quantitative Microdialysis Under Transient Conditions.

Authors:  Shannon L Zandy; Rueben A Gonzales
Journal:  Neurochem Res       Date:  2017-11-10       Impact factor: 3.996

3.  Chronic morphine reduces the readily releasable pool of GABA, a presynaptic mechanism of opioid tolerance.

Authors:  Adrianne R Wilson-Poe; Hyo-Jin Jeong; Christopher W Vaughan
Journal:  J Physiol       Date:  2017-09-07       Impact factor: 5.182

4.  Impairment of adenylyl cyclase-mediated glutamatergic synaptic plasticity in the periaqueductal grey in a rat model of neuropathic pain.

Authors:  Yu-Cheng Ho; Jen-Kun Cheng; Lih-Chu Chiou
Journal:  J Physiol       Date:  2015-05-14       Impact factor: 5.182

5.  Chronic Morphine Reduces Surface Expression of δ-Opioid Receptors in Subregions of Rostral Striatum.

Authors:  Paul M Leah; Emily M L Heath; Bernard W Balleine; Macdonald J Christie
Journal:  Neurochem Res       Date:  2015-06-21       Impact factor: 3.996

6.  Rapid, activity-independent turnover of vesicular transmitter content at a mixed glycine/GABA synapse.

Authors:  Pierre F Apostolides; Laurence O Trussell
Journal:  J Neurosci       Date:  2013-03-13       Impact factor: 6.167

7.  Endocannabinoids control vesicle release mode at midbrain periaqueductal grey inhibitory synapses.

Authors:  Karin R Aubrey; Geoffrey M Drew; Hyo-Jin Jeong; Benjamin K Lau; Christopher W Vaughan
Journal:  J Physiol       Date:  2016-09-15       Impact factor: 5.182

8.  Morphine withdrawal enhances constitutive μ-opioid receptor activity in the ventral tegmental area.

Authors:  Frank J Meye; Ruud van Zessen; Marten P Smidt; Roger A H Adan; Geert M J Ramakers
Journal:  J Neurosci       Date:  2012-11-14       Impact factor: 6.167

Review 9.  Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors.

Authors:  Kurt F Hauser; Pamela E Knapp
Journal:  Int Rev Neurobiol       Date:  2014       Impact factor: 3.230

10.  β-Arrestin-2 knockout prevents development of cellular μ-opioid receptor tolerance but does not affect opioid-withdrawal-related adaptations in single PAG neurons.

Authors:  M Connor; E E Bagley; B C Chieng; M J Christie
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.